Who Will Reinvent Indian Pharma?

For the last three years, Indian pharma has delivered what most industries would envy:* Strong revenue growth* Expanding margins* Clean balance sheets* Consistent cash generationWhy then, should we change? Look closer.What you actually see is an industry that has perfected execution within a model that is quickly becoming obsolete. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit mypharmareviews.substack.com